Viewing Study NCT06363604



Ignite Creation Date: 2024-05-06 @ 8:24 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06363604
Status: RECRUITING
Last Update Posted: 2024-04-12
First Post: 2024-01-21

Brief Title: Evaluation of PWI Assisted by Marshall Ethanolization in Ablation of Persistent Atrial Fibrillation
Sponsor: Xinhua Hospital Shanghai Jiao Tong University School of Medicine
Organization: Xinhua Hospital Shanghai Jiao Tong University School of Medicine

Study Overview

Official Title: Randomized Controlled Study of Atrial Posterior Wall Isolation PWI Assisted by Vein of Marshall Ethanol Infusion VOMEI and Pulmonary Vein Isolation in Persistent Atrial Fibrillation Ablation
Status: RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a prospective randomized controlled single-blind multi-center clinical trial study aiming to investigate whether the strategy of posterior wall isolation PWI assisted by vein of Marshall ethanol infusion VOMEI could improve the success rate of persistent atrial fibrillation ablation
Detailed Description: A total of 260 participants with persistent AF who undergo radiofrequency catheter ablation and received VOMEI PVI will be randomized assigned to two groups at 11 ratio

Group 1 VOMEI PVI linear ablation PWI Group 2 VOMEI PVI linear ablation The major endpoint efficacy endpoint is the recurrence of atrial tachyarrhythmias between 3-12 months during follow-up The secondary endpoint safety endpoint is the occurrence of procedural complications

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None